Blood Clotting Test Device for Children Having Heart Surgery
Part of Blood & lymphatic, Heart & circulation, Injuries & trauma clinical trials.
This study tests a new device called Quantra QPlus that quickly measures how well a child's blood clots during or after heart surgery. It may help doctors manage bleeding and blood-clotting problems more effectively in children.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Child must be under 18 years old
- Child is having heart surgery or is recovering from recent heart surgery with bleeding or clotting concerns
- Parents or guardians must sign a consent form (and child may sign an assent form if required)
- Child must be born at 37 weeks gestation or later (full-term or close to it)
- Child cannot be enrolled in another study that might interfere with results
- Child must not have other medical conditions that would make participation unsafe
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is for children who are having surgery or a procedure with anesthesia. It tests a new device that checks how well their blood clots, to help find normal ranges for kids of different ages.
This trial tests a medicine called 4F-PCC to stop bleeding during complex heart surgery that uses a heart-lung machine. It could help people who have bleeding problems after the surgery.
This trial checks whether a bedside machine (TEG 6s) can measure blood clotting in children during planned surgery. It may help doctors get faster, more accurate information about clotting during the operation.
This study tests a new blood test that measures how well your platelets (clotting cells) work to predict if you might bleed more after heart surgery. The goal is to catch bleeding problems early and help doctors manage them better.
This trial looks at using a blood-clotting test called TEG during certain surgeries in children where bleeding is likely. The goal is to see whether this test helps doctors better manage transfusions (blood or blood products) during and after the operation.
This study tests a quick bedside measurement of how well the drug tranexamic acid works to prevent bleeding during heart surgery. It may help doctors give the right dose to reduce blood loss.
Hear when a new Blood Loss, Surgical trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.